Compare PRPO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | IPWR |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 37.0M |
| IPO Year | 2000 | 2013 |
| Metric | PRPO | IPWR |
|---|---|---|
| Price | $28.40 | $3.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 12.0K | ★ 42.3K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | $2,603.56 |
| Revenue Next Year | N/A | $1,800.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $5.21 | $2.62 |
| 52 Week High | $29.53 | $6.90 |
| Indicator | PRPO | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 60.49 | 55.86 |
| Support Level | $22.96 | $3.11 |
| Resistance Level | N/A | $3.33 |
| Average True Range (ATR) | 1.68 | 0.26 |
| MACD | 0.20 | 0.04 |
| Stochastic Oscillator | 99.81 | 98.51 |
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.